1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said ...

RELATED: The No. 1 Ozempic Side Effect “Nobody Warns About.” ...

The landscape of triple-negative breast cancer (TNBC) is shifting rapidly. What was once a landscape dominated by standard cytotoxic chemotherapy is now a complex map of immunotherapy, PARP inhibitors ...

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on ...

Emerging evidence suggests that the widely used diabetes drug metformin, when taken early in a Covid-19 infection, may ...

GSK PLC (GSK) reports robust growth in specialty medicines and vaccines, with a focus on advancing key assets in oncology and ...

Following the Nipah virus outbreak in India, we asked experts about ongoing research into treatments, if there is a cause for concern, and whether they think another quarantine situation is likely.

Consumers are increasingly looking beyond pills and foams. Topical serums, natural compounds, and growth-factor therapies now ...

On this World Cancer Day, we look at where research and availability stand for cancer vaccines.

Mr Wright said Australia’s cautious regulatory stance mirrors the US and Japan, which are also pursuing flexible, risk-based frameworks. This contrasts with the EU’s prescriptive AI Act, which many ...

Luke Miels had only been at the helm of GSK for 20 days before he signed off on his first multibillion-dollar buyout, and the CEO is clear on what else will attract his interest. | Luke Miels had only ...